Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications.

Setoguchi S, Wang PS, Alan Brookhart M, Canning CF, Kaci L, Schneeweiss S.

J Am Geriatr Soc. 2008 Sep;56(9):1644-50. doi: 10.1111/j.1532-5415.2008.01839.x. Epub 2008 Aug 4.

PMID:
18691283
2.

Risk of death in elderly users of conventional vs. atypical antipsychotic medications.

Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA.

N Engl J Med. 2005 Dec 1;353(22):2335-41.

3.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
4.

Antipsychotic drug use and mortality in older adults with dementia.

Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA.

Ann Intern Med. 2007 Jun 5;146(11):775-86.

PMID:
17548409
5.

Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.

Liperoti R, Pedone C, Lapane KL, Mor V, Bernabei R, Gambassi G.

Arch Intern Med. 2005 Dec 12-26;165(22):2677-82.

PMID:
16344428
6.

Antipsychotics and the risk of sudden cardiac death.

Ray WA, Meredith S, Thapa PB, Meador KG, Hall K, Murray KT.

Arch Gen Psychiatry. 2001 Dec;58(12):1161-7.

PMID:
11735845
7.

Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.

Mehta S, Johnson ML, Chen H, Aparasu RR.

J Clin Psychiatry. 2010 Jun;71(6):689-98. doi: 10.4088/JCP.09m05817yel.

PMID:
20573328
8.

Neither atypical nor conventional antipsychotics increase mortality or hospital admissions among elderly patients with dementia: a two-year prospective study.

Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkälä KH.

Am J Geriatr Psychiatry. 2007 May;15(5):416-24.

PMID:
17463191
9.

Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.

Aparasu RR, Jano E, Johnson ML, Chen H.

Am J Geriatr Pharmacother. 2008 Oct;6(4):198-204. doi: 10.1016/j.amjopharm.2008.10.003.

PMID:
19028375
10.

Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients.

Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS.

CMAJ. 2007 Feb 27;176(5):627-32. Erratum in: CMAJ. 2007 May 22;176(11):1613.

11.

Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes.

Huybrechts KF, Rothman KJ, Silliman RA, Brookhart MA, Schneeweiss S.

CMAJ. 2011 Apr 19;183(7):E411-9. doi: 10.1503/cmaj.101406. Epub 2011 Mar 28.

12.

Perceived stress and cause-specific mortality among men and women: results from a prospective cohort study.

Nielsen NR, Kristensen TS, Schnohr P, Grønbaek M.

Am J Epidemiol. 2008 Sep 1;168(5):481-91; discussion 492-6. doi: 10.1093/aje/kwn157. Epub 2008 Jul 8.

PMID:
18611955
13.

Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease.

Lee TA, Pickard AS, Au DH, Bartle B, Weiss KB.

Ann Intern Med. 2008 Sep 16;149(6):380-90.

PMID:
18794557
14.

Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease.

Lee TA, Schumock GT, Bartle B, Pickard AS.

Pharmacotherapy. 2009 Sep;29(9):1039-53. doi: 10.1592/phco.29.9.1039.

PMID:
19698009
15.

Risk of death associated with the use of conventional vs. atypical antipsychotic medications: evaluating the use of the Emilia-Romagna Region database for pharmacoepidemiological studies.

Sikirica S, Marino M, Gagne JJ, De Palma R, Maio V.

J Clin Pharm Ther. 2014 Feb;39(1):38-44. doi: 10.1111/jcpt.12099. Epub 2013 Sep 16.

PMID:
24102411
16.

Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents.

Aparasu RR, Chatterjee S, Mehta S, Chen H.

Med Care. 2012 Nov;50(11):961-9. doi: 10.1097/MLR.0b013e31826ec185.

PMID:
23047786
17.

Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE; Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group.

Circulation. 2002 Oct 1;106(14):1777-82.

18.

Mortality in current and former users of clozapine.

Walker AM, Lanza LL, Arellano F, Rothman KJ.

Epidemiology. 1997 Nov;8(6):671-7.

PMID:
9345668
19.

Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents.

McIntyre RS, Jerrell JM.

Arch Pediatr Adolesc Med. 2008 Oct;162(10):929-35. doi: 10.1001/archpedi.162.10.929.

PMID:
18838645
20.

Antipsychotic drug use and risk of pneumonia in elderly people.

Knol W, van Marum RJ, Jansen PA, Souverein PC, Schobben AF, Egberts AC.

J Am Geriatr Soc. 2008 Apr;56(4):661-6. doi: 10.1111/j.1532-5415.2007.01625.x. Epub 2008 Feb 7.

PMID:
18266664

Supplemental Content

Support Center